Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tekla Healthcare Investors
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tekla Healthcare Investors since year 2005.
Table 2 shows the detailed insider transactions of Tekla Healthcare Investors since 2005.
The reporting company's ticker symbol is HQH. The reporting company's CIK number is 805267.
The total value of stock buying since 2005 is $800,760.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-10 | 9,382 | $196,876 | 0 | $0 | 0 | $0 |
| 2018-01 | 1,100 | $26,604 | 0 | $0 | 0 | $0 |
| 2016-01 | 862 | $24,978 | 0 | $0 | 0 | $0 |
| 2015-06 | 2,000 | $71,480 | 0 | $0 | 0 | $0 |
| 2013-06 | 5,000 | $107,265 | 0 | $0 | 0 | $0 |
| 2012-03 | 1,496 | $23,710 | 0 | $0 | 0 | $0 |
| 2011-08 | 8,100 | $100,221 | 0 | $0 | 0 | $0 |
| 2009-09 | 1,000 | $10,510 | 0 | $0 | 0 | $0 |
| 2009-08 | 3,000 | $32,099 | 0 | $0 | 0 | $0 |
| 2008-11 | 2,000 | $17,940 | 0 | $0 | 0 | $0 |
| 2008-10 | 387 | $4,411 | 0 | $0 | 0 | $0 |
| 2007-11 | 1,500 | $23,722 | 0 | $0 | 0 | $0 |
| 2007-10 | 4,500 | $78,297 | 0 | $0 | 0 | $0 |
| 2007-08 | 2,000 | $33,420 | 0 | $0 | 0 | $0 |
| 2006-12 | 3,000 | $49,227 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-25 | Omstead Daniel R (President) | Buy | 5,500 | 20.43 | 112,342 |
| 2018-10-17 | Omstead Daniel R (President) | Buy | 3,882 | 21.78 | 84,534 |
| 2018-01-25 | Kent Thomas M (Director) | Buy | 1,100 | 24.19 | 26,604 |
| 2016-01-06 | Gasperoni Timothy L (Other) | Buy | 862 | 28.98 | 24,978 |
| 2015-06-29 | Stebbins Lucinda H (Director) | Buy | 2,000 | 35.74 | 71,480 |
| 2013-06-04 | Omstead Daniel R (President) | Buy | 5,000 | 21.45 | 107,265 |
| 2012-03-19 | Pohotsky Oleg M (Director) | Buy | 200 | 16.00 | 3,200 |
| 2012-03-09 | Bonney Michael W (Director) | Buy | 650 | 15.80 | 10,268 |
| 2012-03-09 | Reardon William S (Director) | Buy | 646 | 15.86 | 10,242 |
| 2011-08-08 | Omstead Daniel R (President) | Buy | 8,100 | 12.37 | 100,221 |
| 2009-09-03 | Stebbins Lucinda H (Director) | Buy | 1,000 | 10.51 | 10,510 |
| 2009-08-06 | Omstead Daniel R (President) | Buy | 3,000 | 10.70 | 32,099 |
| 2008-11-26 | Omstead Daniel R (President) | Buy | 2,000 | 8.97 | 17,940 |
| 2008-10-10 | Omstead Daniel R (President) | Buy | 387 | 11.40 | 4,411 |
| 2007-11-21 | Omstead Daniel R (President) | Buy | 1,500 | 15.81 | 23,722 |
| 2007-10-03 | Omstead Daniel R (President) | Buy | 3,000 | 17.40 | 52,198 |
| 2007-08-21 | Stebbins Lucinda H (Director) | Buy | 1,000 | 16.63 | 16,630 |
| 2007-08-03 | Omstead Daniel R (President) | Buy | 1,000 | 16.79 | 16,790 |
| 2006-12-27 | Stebbins Lucinda H (Director) | Buy | 3,000 | 16.41 | 49,227 |
Insider trading activities including stock purchases, stock sales, and option exercises of HQH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tekla Healthcare Investors (symbol HQH, CIK number 805267) see the Securities and Exchange Commission (SEC) website.